Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dickhoff

Showing results (221-230 of 231) with videos related to

Pageof 24
Sort By:
Heart Rhythm|February 25, 2024
ECG-only explainable deep learning algorithm predicts the risk for malignant ventricular arrhythmia in phospholamban cardiomyopathyRutger R van de Leur, Remco de Brouwer, Hidde Bleijendaal, et al.
European Heart Journal|June 11, 2021
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk predictionTom E Verstraelen, Freyja H M van Lint, Laurens P Bosman, et al.
JAMA Surgery|June 25, 2025
Intercostal or Paravertebral Block vs Thoracic Epidural in Lung Surgery: A Randomized Noninferiority TrialLouisa N Spaans, Marcel G W Dijkgraaf, Denis Susa, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2019
Biochemically Silent Sympathetic Paraganglioma, Pheochromocytoma, or Metastatic Disease in SDHD Mutation CarriersKoen M A Dreijerink, Johannes A Rijken, C J Compaijen, et al.
JACC. Heart Failure|August 9, 2025
Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)-Positive IndividualsMyrthe Y C van der Heide, Tom E Verstraelen, Remco de Brouwer, et al.
European Journal of Heart Failure|April 23, 2025
Age-related penetrance of phospholamban p.Arg14del cardiomyopathyTom E Verstraelen, Freyja H M van Lint, Remco de Brouwer, et al.
The Lancet. Respiratory Medicine|March 27, 2026
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaborationAnne-Marie C Dingemans, Isabelle Opitz, Alessandro Brunelli, et al.
Lung Cancer (Amsterdam, Netherlands)|October 18, 2025
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer GroupMariana Brandão, Elena Prisciandaro, Eleni Xenophontos, et al.
Calcified Tissue International|November 13, 2024
Adapting to Adulthood: A Review of Transition Strategies for Osteogenesis ImperfectaLuca Celli, Mark R Garrelfs, Ralph J B Sakkers, et al.
Frontiers in Endocrinology|August 28, 2020
Collaboration Around Rare Bone Diseases Leads to the Unique Organizational Incentive of the Amsterdam Bone CenterElisabeth M W Eekhoff, Dimitra Micha, Tymour Forouzanfar, et al.
Pageof 24

Showing results (221-230 of 231) with videos related to

Sort By:
Pageof 24
Heart Rhythm|February 25, 2024
ECG-only explainable deep learning algorithm predicts the risk for malignant ventricular arrhythmia in phospholamban cardiomyopathyRutger R van de Leur, Remco de Brouwer, Hidde Bleijendaal, et al.
European Heart Journal|June 11, 2021
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk predictionTom E Verstraelen, Freyja H M van Lint, Laurens P Bosman, et al.
JAMA Surgery|June 25, 2025
Intercostal or Paravertebral Block vs Thoracic Epidural in Lung Surgery: A Randomized Noninferiority TrialLouisa N Spaans, Marcel G W Dijkgraaf, Denis Susa, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2019
Biochemically Silent Sympathetic Paraganglioma, Pheochromocytoma, or Metastatic Disease in SDHD Mutation CarriersKoen M A Dreijerink, Johannes A Rijken, C J Compaijen, et al.
JACC. Heart Failure|August 9, 2025
Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)-Positive IndividualsMyrthe Y C van der Heide, Tom E Verstraelen, Remco de Brouwer, et al.
European Journal of Heart Failure|April 23, 2025
Age-related penetrance of phospholamban p.Arg14del cardiomyopathyTom E Verstraelen, Freyja H M van Lint, Remco de Brouwer, et al.
The Lancet. Respiratory Medicine|March 27, 2026
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaborationAnne-Marie C Dingemans, Isabelle Opitz, Alessandro Brunelli, et al.
Lung Cancer (Amsterdam, Netherlands)|October 18, 2025
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer GroupMariana Brandão, Elena Prisciandaro, Eleni Xenophontos, et al.
Calcified Tissue International|November 13, 2024
Adapting to Adulthood: A Review of Transition Strategies for Osteogenesis ImperfectaLuca Celli, Mark R Garrelfs, Ralph J B Sakkers, et al.
Frontiers in Endocrinology|August 28, 2020
Collaboration Around Rare Bone Diseases Leads to the Unique Organizational Incentive of the Amsterdam Bone CenterElisabeth M W Eekhoff, Dimitra Micha, Tymour Forouzanfar, et al.
Pageof 24